Ronan MacLoughlin
Overview
Explore the profile of Ronan MacLoughlin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
928
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hussain M, Goyal A, Goyal K, S R, Nellore J, Shahwan M, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2025 Mar;
PMID: 40047857
Inflammatory lung diseases (ILDs) such as asthma, acute respiratory distress syndrome, bronchiectasis, chronic obstructive pulmonary disease, COVID-19, cystic fibrosis, and lung cancer impose a substantial worldwide healthcare impact. The pathophysiology...
2.
Thapa R, Marianesan A, Rekha A, Ganesan S, Kumari M, Bhat A, et al.
Biogerontology
. 2025 Feb;
26(2):64.
PMID: 40011266
Cellular senescence and hypoxia-inducible factor (HIF) signaling are crucial in pulmonary aging and age-related lung diseases such as chronic obstructive pulmonary disease idiopathic pulmonary fibrosis and lung cancer. HIF plays...
3.
Soleymani S, Doroudian M, Soezi M, Beladi A, Asgari K, Mobarakshahi A, et al.
Oncol Res
. 2024 Dec;
33(1):15-26.
PMID: 39735671
Brain metastasis and primary glioblastoma multiforme represent the most common and lethal malignant brain tumors. Its median survival time is typically less than a year after diagnosis. One of the...
4.
Baldry M, Costa C, Zeroual Y, Cayet D, Pardessus J, Soulard D, et al.
Antimicrob Agents Chemother
. 2024 Oct;
68(12):e0086624.
PMID: 39480071
Novel therapeutic strategies are urgently needed to combat pneumonia caused by strains resistant to standard-of-care antibiotics. Previous studies have shown that targeted stimulation of lung innate immune defenses through intranasal...
5.
Vatzia E, Paudyal B, Dema B, Carr B, Sedaghat-Rostami E, Gubbins S, et al.
NPJ Vaccines
. 2024 Oct;
9(1):188.
PMID: 39397062
Current influenza vaccines are strain-specific and require frequent updates to combat new strains, making a broadly protective influenza vaccine (BPIV) highly desirable. A promising strategy is to induce T-cell responses...
6.
Hussain M, Gupta G, Ghaboura N, Moglad E, Almalki W, Alzarea S, et al.
Clin Chim Acta
. 2024 Oct;
565:119983.
PMID: 39368685
Exosomal non-coding RNAs (ncRNAs) have become essential contributors to advancing and treating lung cancers (LCs). The development of liquid biopsies that utilize exosomal ncRNAs (exo-ncRNAs) offers an encouraging method for...
7.
Thapa R, Moglad E, Goyal A, Bhat A, Almalki W, Kazmi I, et al.
EXCLI J
. 2024 Sep;
23:991-1017.
PMID: 39253534
One of the main causes of death worldwide is lung cancer, which is largely caused by cigarette smoking. The crucial transcription factor NF-κB, which controls inflammatory responses and various cellular...
8.
Walsh M, Mac Giolla Eain M, MacLoughlin R, Laffey J, McNicholas B
Intensive Care Med Exp
. 2024 Aug;
12(1):73.
PMID: 39186127
No abstract available.
9.
Kokkinis S, De Rubis G, Paudel K, Patel V, Yeung S, Jessamine V, et al.
Pathol Res Pract
. 2024 Jun;
260:155423.
PMID: 38909404
Curcumin, the principal curcuminoid of turmeric (Curcuma longa extract), is very well known for its multiple biological therapeutic activities, particularly its anti-inflammatory and antioxidant potential. However, due to its low...
10.
De Rubis G, Paudel K, Vishwas S, Kokkinis S, Chellappan D, Gupta G, et al.
Pathol Res Pract
. 2024 Jun;
260:155387.
PMID: 38870713
Lung cancer (LC) is the leading cause of cancer-related mortality, and it is caused by many factors including cigarette smoking. Despite numerous treatment strategies for LC, its five-year survival is...